DRUG POLICY ACTIONPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jun 1
Assets in 2024 (Year End)
$19,735,187
Cash & Equivalents
55%
Investments
45%
Prepaid Expenses
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$1,439,430
Grants Payable
60%
Payables & Accruals
28%
Other Liabilities
12%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$10,763,354
$10,905,009
+1%
Receivables (Non-Related)
$1,500,000
$0
-100%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$0
$5,568
-
Investments
$8,150,521
$8,824,610
+8%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$20,413,875
$19,735,187
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$51,000
$403,689
+692%
Grants Payable
$5,301,000
$860,000
-84%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$67,351
$175,741
+161%
Total Liabilities
$5,419,351
$1,439,430
-73%
Net assets
2023
2024
Change
Restricted Net Assets
$2,733,698
$64,897
-98%
Unrestricted Net Assets
$12,260,826
$18,230,860
+49%
Net assets
2023
2024
Change
Net assets
+$14,994,524
+$18,295,757
+22%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)